Existing drug reduces pain in young sickle cell anaemia patients

Existing drug reduces pain in young sickle cell anaemia patients


A cancer drug already used to treat adults and school-age children with sickle cell anaemia is safe and significantly reduces pain and other complications of the disease in children as young as 9 months, according to a national study involving a University of Texas Southwestern Medical Center researcher.
Paediatric researchers at UT Southwestern and 13 other academic medical

Medical Insurance